(Q37881175)

24 August 2017

1 reference

title

Suicidality and epilepsy: a neuropsychobiological perspective (English)

1 reference

24 August 2017

0 references

0 references

0 references

Hrvoje Hecimovic

1

0 references

author name string

Jay Salpekar

series ordinal

2

1 reference

24 August 2017

Andres M Kanner

series ordinal

3

1 reference

24 August 2017

John J Barry

series ordinal

4

1 reference

24 August 2017

publication date

26 May 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

22

1 reference

24 August 2017

issue

1

1 reference

24 August 2017

page(s)

77-84

1 reference

Epilepsy and risk of suicide: a population-based case-control study

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Suicidality and epilepsy: a complex relationship that remains misunderstood and underestimated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

The FDA alert on suicidality and antiepileptic drugs: Fire or false alarm?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Depression and suicide attempt as risk factors for incident unprovoked seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

An incident case-referent study of epileptic seizures in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Major depression is a risk factor for seizures in older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Anxiety disorders, subsyndromic depressive episodes, and major depressive episodes: do they differ on their impact on the quality of life of patients with epilepsy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Anxiety disorders and risk for suicidal ideation and suicide attempts: a population-based longitudinal study of adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

5-HT1A receptor binding in temporal lobe epilepsy patients with and without major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Brain Serotonin1A Receptor Binding Measured by Positron Emission Tomography With [11C]WAY-100635

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

The effect of antiepileptic drugs on 5-HT-receptor binding measured by positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

The concentration of neurotransmitter metabolites in the cerebrospinal fluid of suicidal individuals: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Genetics of the serotonergic system in suicidal behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Impairment of inhibitory control of the hypothalamic pituitary adrenocortical system in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Elevated plasma corticosterone level and depressive behavior in experimental temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

The acceleration of amygdala kindling epileptogenesis by chronic low-dose corticosterone involves both mineralocorticoid and glucocorticoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

POSSIBILITY OF A BIOCHEMICAL TEST FOR SUICIDAL POTENTIAL: AN ANALYSIS OF ENDOCRINE FINDINGS PRIOR TO THREE SUICIDES.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

HPA axis hyperactivity and attempted suicide in young adult mood disorder inpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

DST abnormality as a predictor of course in major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

The dexamethasone suppression test and completed suicide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

The dexamethasone suppression test and suicide prediction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

CSF 5-HIAA and DST non-suppression -independent biomarkers in suicide attempters?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

[Neurobiological correlates of suicidal behavior]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

How do the many etiologies of West syndrome lead to excitability and seizures? The corticotropin releasing hormone excess hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Low glial numbers in the amygdala in major depressive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Glial cell abnormalities in major psychiatric disorders: the evidence and implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Glial reduction in the subgenual prefrontal cortex in mood disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Glucocorticoid receptor pathways are involved in the inhibition of astrocyte proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

GABAergic dysfunction in mood disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Beyond monoamines: glutamatergic function in mood disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Depression and epilepsy: A bidirectional relation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Which factors may play a pivotal role on determining the type of psychiatric disorder in children and adolescents with epilepsy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

10-year research update review: psychiatric problems in children with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Overrepresentation of epileptics in a consecutive series of suicide attempters seen at a children's hospital, 1978-1983

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Depression and anxiety disorders in pediatric epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Is major depression a neurologic disorder with psychiatric symptoms?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Advances in empirically based assessment: revised cross-informant syndromes and new DSM-oriented scales for the CBCL, YSR, and TRF: comment on Lengua, Sadowksi, Friedrich, and Fischer (2001).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Neurochemical underpinnings in bipolar disorder and epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Clinical experience with anticonvulsant medication in pediatric epilepsy and comorbid bipolar spectrum disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Epilepsy, suicidal behaviour, and depression: do they share common pathogenic mechanisms?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Patient-validated content of epilepsy-specific quality-of-life measurement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Serotonin inhibits epileptiform discharge by activation of 5-HT1A receptors in CA1 pyramidal neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy: an [18F]MPPF-PET study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Association of serotonin transporter promoter (5-HTTLPR) and intron 2 (VNTR-2) polymorphisms with treatment response in temporal lobe epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Deep brain stimulation for treatment-resistant depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

Psychiatric comorbidity, health, and function in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

The children's depression inventory: a systematic evaluation of psychometric properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.04.059

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YEBEH.2011.04.059

1 reference

24 August 2017

1 reference